Manitex Capital Inc.
TSX VENTURE : MNX

June 29, 2005 09:30 ET

Manitex's Subsidiary Hywood Pharmachem Re-Organizes its Capital

MONTREAL, QUEBEC--(CCNMatthews - June 29, 2005) - Manitex Capital Inc. (TSX VENTURE:MNX) announced today that, effective March 1, 2005, its subsidiary Hywood Pharmachem Inc., a chemical distributor, underwent a share re-organization resulting in the issuance of 1,121,491 participating Class "F1" shares redeemable at $1.00 per share. As a result, Manitex received 841,118 Class "F1" shares and 63.75% of a new series of Class "A" participating shares.

About Manitex Capital Inc.

Manitex is a diversified investment company. It focuses on acquiring control of significant minority positions in emerging and established companies and actively participates in building shareholder value. Manitex currently has 12,361,276 common shares outstanding which are quoted for trading on the TSX Venture Exchange (TSX VENTURE:MNX).

This document may contain certain forward-looking information and statements concerning the Company's operations, performance and financial condition, including, in particular, the likelihood of the Company's success in developing and expanding its business. These statements are based upon a number of assumptions and estimates that are inherently subject to significant uncertainties and contingencies, many of which are beyond the control of the Company. Actual results may differ materially from those expressed or implied by such forward-looking statements.


Contact Information

  • Manitex Capital Inc.
    Steve Saviuk
    Chief Executive Officer
    (514) 693-8830
    (514) 694-0443 (FAX)